Navigation Links
FASEB announces 2014 Science Conference: Yeast Chromosome Structure, Replication & Segregation
Date:1/22/2014

Bethesda, MD This 2014 FASEB Science Research Conference focuses on recent advances in our understanding of the molecular mechanisms that control genome integrity and cell division. Studies using yeast as model organisms continue to drive the development of innovative approaches and powerful new technologies that ensure a rapid pace of fundamental discoveries in these research areas and provide insights into these mechanisms in higher eukaryotes.

Presentations of unpublished data and stimulating informal discussions lead to the dissemination of new concepts, integration of research ideas, propel the generation of creative new ideas, and fuel the development of new collaborations. This conference brings together an international community of scientists studying different aspects of chromosome metabolism including telomere and centromere biology, control of segregation, meiosis, recombination, and repair using diverse yeast species.

As the premier specialized international conference in this field, the meeting creates a singular environment that consistently attracts both leaders and newcomers in the chromosome dynamics field for a vibrant cross-fertilization of ideas and forging productive new research directions.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces 2014 Science Research Conference: Skeletal Muscle Satellite and Stem Cells
2. FASEB announces 2014 Science Research Conference: Lipid and Lipid Regulated Kinases in Cancer
3. FASEB announces 2014 Science Research Conference: Folic Acid, Vitamin B12 and One Carbon Metabolism
4. FASEB announces 2014 SRC: Phospholipid Cell Signaling & Metabolism in Inflammation & Cancer
5. FASEB announces 2014 Science Research Conference: Molecular Biophysics of Membranes
6. FASEB announces 2014 SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
7. FASEB announces 2014 Science Research Conference: Nutrient Sensing and Metabolic Signaling
8. FASEB announces 2014 Science Research Conference: Retinal Neurobiology and Visual Processing
9. FASEB announces 2014 Science Research Conference: Virus Structure and Assembly
10. FASEB announces 2014 Science Research Conference: Protein Folding in the Cell
11. FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
(Date:2/8/2017)... Report Highlights The global biosurgery market should ... 2016 at a compound annual growth rate (CAGR) of ... An overview of the global market for biosurgery. - ... and 2016, and projections of compound annual growth rates ... the basis of product type, source, application, and region. ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... February 27, 2017 A Europe-wide survey of ... researchers using animals in their research treat them with due care. ... and detailed analysis of the results indicates that there is a ... to put into practice the principles of the 3Rs (Refine, ... What ...
(Date:2/27/2017)... Feb. 27, 2017 AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... the U.S. Food and Drug Administration (FDA) has ... section 505(b)(2) for DSUVIA™ (formerly ARX-04) (sufentanil sublingual ... with moderate-to-severe acute pain in a medically supervised ...
(Date:2/27/2017)... and HAMILTON, Bermuda ... (NASDAQ: ADXS ) and ... companies focused on developing cancer immunotherapies, today announced ... develop a novel cancer immunotherapy agent using Advaxis, ... SELLAS, patented WT1 targeted heteroclitic peptide antigen mixture ...
(Date:2/27/2017)... ... February 27, 2017 , ... In starting a program to hire ... grandfather, “Hire for attitude. Train for skill.” , In keeping with this philosophy, the ... as a salesman. Zamzow is hoping to replicate the practice throughout the company. , ...
Breaking Biology Technology: